Coronation Fund Managers Ltd. has reduced its stake in Elevance Health (NYSE:ELV) by 7.2%, selling 9,872 shares to hold 127,495 shares valued at $41.2 million. This position represents 2.1% of Coronation’s portfolio. The article also notes mixed analyst sentiments, with Zacks lowering some near-term EPS estimates while raising a Q4 2027 forecast, and MarketBeat’s consensus being a “Moderate Buy” with an average target price of $390.55.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Coronation Fund Managers Ltd. Sells 9,872 Shares of Elevance Health, Inc. $ELV
Coronation Fund Managers Ltd. has reduced its stake in Elevance Health (NYSE:ELV) by 7.2%, selling 9,872 shares to hold 127,495 shares valued at $41.2 million. This position represents 2.1% of Coronation’s portfolio. The article also notes mixed analyst sentiments, with Zacks lowering some near-term EPS estimates while raising a Q4 2027 forecast, and MarketBeat’s consensus being a “Moderate Buy” with an average target price of $390.55.